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Experimental
General Information
Unless otherwise noted all starting materials were either known compounds or were obtained from commercial sources and used without purification. Melting points were determined in open capillaries. IR spectra were taken on a FT-IR-Tensor 27 spectrometer. 1 H NMR ( 13 C NMR) spectra were measured on a Bruker DPX 400 MHz spectrometer in CDCl3 (or DMSO-d6) with chemical shift (δ) given in ppm relative to TMS as internal standard [(s = singlet, d = doublet, t = triplet, brs = broad singlet, m = multiplet), coupling constant (Hz)]. HRMS (APCI-TOF) was determined by using microTOF-QⅡ HRMS/MS instrument (BRUKER). X-Ray crystallographic analysis was performed with a Siemens SMART CCD and a Siemens P4 diffractometer. 
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Experimental Section Preparation of Compound 1a:
A mixture of 2-(phenylethynyl)benzaldehyde (5 mmol), p-tolylethanone (0.67 g, 5 mmol), NaOH ( 0.8g, 20 mmol) and EtOH (20.0 mL) were added in a 50-mL reaction vial. Then, the mixture was stirred at 0 o C for 20 min, and the followed reaction system was stirred at room temperature. After completion of the reaction monitored by TLC, the reaction system was poured into the cold water, and the solid product was collected by Büchner filtration. The desired pure 3-(2-(phenylethynyl)phenyl)-1-(p-tolyl)prop-2-en-1-one (1a) was obtained in 80% yield by recrystallization from 95% EtOH.
Preparation of Compound 3a: 7-Methyl-5-phenyl-11-tosyl-11H-benzo[b]fluoren-10-ol
A mixture of 3-(2-(phenylethynyl)phenyl)-1-(p-tolyl)prop-2-en-1-one (1a, 0.25 mmol, 1.0 equiv.), tosylhydrazide (2a, 0.5 mmol, 2.0 equiv.), BPO (1.0 mmol, 4.0 equiv.), PivOH (0.5 mmol, 2.0 equiv.), TBAI (0.05 mmol, 0.20 equiv.), Cu(OAc)2 (0.0125 mmol, 0.05 equiv), MeCN (2.0 mL) were added in a sealed 10-mL reaction vial. Then, the mixture was stirred at 100 o C for 12 h until complete consumption of the starting material 1a as detected by TLC. The mixture was cooled to room temperature and evaporated under vacuum. The crude mixture was purified by flash column chromatography (petroleum ether /ethyl acetate) to afford the desired product 7-methyl-5-phenyl-11-tosyl-11H-benzo[b]fluoren-10-ol (3a) in 71% yield. -5-(p-tolyl)-11-tosyl-11H-benzo[b]fluoren-10-ol (3i : 1-(4-Chlorophenyl)-3-phenyl-3-tosylpropan-1-one A mixture of 1-(4-chlorophenyl)-3-phenylprop-2-en-1-one (4a, 0.25 mmol, 1.0 equiv.), tosylhydrazide (2a, 0.5 mmol, 2.0 equiv.), BPO (0.50 mmol, 2.0 equiv.), TBHP (0.25 mol, 1.0 equiv., 70% in water), TBAI (0.05 mmol, 0.2 equiv.), MeCN (2.5 mL) were added in a sealed 10-mL reaction vial. Then, the mixture was stirred in oil bath at 100 o C for 6 h until complete consumption of the starting material 4a as detected by TLC. The mixture was cooled to room temperature and evaporated under vacuum. The crude mixture was purified by flash column chromatography (petroleum ether /ethyl acetate) to afford the desired product 5a in 77% yield. Chlorophenyl)-3-phenyl-3-(phenylsulfonyl)propan-1-one (5c 3-(4-Bromophenyl)-3-(phenylsulfonyl)-1-(m-tolyl)propan-1-one (5i 
11-((4-(Tert-butyl)phenyl)sulfonyl)-7-methyl-5-phenyl-11H-benzo[b]fluoren-10-ol (3d)
Yellow
5-(4-Chlorophenyl)-7-methyl-11-tosyl-11H-benzo[b]fluoren-10-ol (3f)
7-Methyl-5-(naphthalen-1-yl)-11-tosyl-11H-benzo[b]fluoren-10-ol (3g)
7-Bromo-5-(4-methoxyphenyl)-11-tosyl-11H-benzo[b]fluoren-10-ol (3h)
7-Bromo
5-Phenyl-11-tosyl-11H-benzo[b]fluoren-10-ol (3k)
5-(4-Chlorophenyl)-11-(phenylsulfonyl)-11H-benzo[b]fluoren-10-ol (3m)
Preparation of Compound 5a
1-(4-
